You are here
SAFE Opioid Prescribing: Strategies. Assessment. Fundamentals. Education.
The need for education that will help medical professionals respond to the opioid epidemic is increasing.
According to a Medicare and Medicaid Research Review report on Jan. 1, 2016, the rate of deaths from drug overdoses in the U.S. since 2000 has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). On March 24, the FDA announced that immediate-release opioid painkillers would carry a "black box" warning about the risk of abuse, addiction, overdose and death, a measure intended to educate physicians when prescribing.
To address this critical need, ACP has launched the online recording of a pre-course from the 2016 Internal Medicine Meeting called SAFE Opioid Prescribing: Strategies. Assessment. Fundamentals. Education. You can access the recordings with the link below.
No registration fee is required to use this pre-course, which will expire July 15, 2017.
The activity features six, half-hour educational segments, plus questions and answers facilitated by expert faculty.
This SAFE Opioid Prescribing Pre-Course – a Risk Evaluation and Mitigation Strategy (REMS) activity – allows you to leave the site and return to complete it in segments, depending on your schedule. To earn credits and points, you must complete all six modules and correctly answer at least seven of 12 medical knowledge questions.
The SAFE Opioid Prescribing pre-course provides guidance that is essential for safe and effective pain management when using extended (ER) and long-activing (LA) opioids. It is critical to recognize best practices for how to start to therapy with ER/LA, how to provide therapy, how to end therapy, and what to do in between. Evidence-based tools are required for screening patients at risk and for monitoring for adherence to prescribed ER/LA opioids. Proven methods to counsel patients on ER/LA opioids and to achieve positive outcomes need to be employed. Comprehensive information is also essential on ER/LA-opioids as a drug class. This recorded pre-course will provide clinical insights from specific ER/LA product information sources.
CME Credit and MOC Points
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The ACP designates this enduring material for 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 points and patient safety credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. Those who complete this activity will also earn a REMS Certificate of Completion (shown above).
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS program companies. See a list of all member companies. This activity is fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the U.S. Food & Drug Administration (FDA).